title: Long-term results of conversion from existing to microemulsion formulation of cyclosporine.
authors.affiliation: Department of Medicine-Nephrology, Humboldt University of Berlin, Germany.
authors.forename: H H
authors.initials: HH
authors.lastname: Neumayer
authors.forename: L
authors.initials: L
authors.lastname: Färber
authors.forename: K
authors.initials: K
authors.lastname: Budde
authors.forename: R
authors.initials: R
authors.lastname: Kohnen
authors.forename: A
authors.initials: A
authors.lastname: Maibücher
authors.forename: A
authors.initials: A
authors.lastname: Schuster
authors.forename: J
authors.initials: J
authors.lastname: Vollmar
authors.forename: J
authors.initials: J
authors.lastname: Waiser
authors.forename: F C
authors.initials: FC
authors.lastname: Luft
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004304:Dosage Forms; D004655:Emulsions; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006339:Heart Rate; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D013997:Time Factors
chemical_list: D004304:Dosage Forms; D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine